(Q40994540)

25 September 2017

Long-term follow-up of Graves ophthalmopathy in an incidence cohort (English)

1 reference

25 September 2017

Graves' ophthalmopathy

1 reference

4

1 reference

25 September 2017

Bartley GB

1

1 reference

25 September 2017

Fatourechi V

2

1 reference

25 September 2017

Kadrmas EF

3

1 reference

25 September 2017

Ilstrup DM

5

1 reference

25 September 2017

Garrity JA

6

1 reference

25 September 2017

Gorman CA

7

1 reference

25 September 2017

1 June 1996

1 reference

25 September 2017

1 reference

25 September 2017

103

1 reference

25 September 2017

6

1 reference

25 September 2017

958-962

1 reference

The Incidence of Graves' Ophthalmopathy in Olmsted County, Minnesota

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Clinical features of Graves' ophthalmopathy in an incidence cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

The treatment of Graves' ophthalmopathy in an incidence cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Natural History Study of Congenital Heart Defects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Natural history of thyroid associated ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Dysthyroid optic neuropathy. Clinical profile and rationale for management

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Visual field defects in exophthalmos associated with thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Visual changes in progressive exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Optic neuropathy of exophthalmic goiter (Graves' disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

A retrospective review of 26 cases of dysthyroid optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

Graves ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930579-4

7 January 2021

10.1016/S0161-6420(96)30579-4

Identifiers

DOI

1 reference

25 September 2017

1 reference